Colorectal Carcinoma: Is There Any Correlation between Her2/neu Expression, Ki-67 Score, and Tumor Budding and Clinicopathological Parameters?—A Prospective Institution-Based Study

Colorectal Carcinoma: Is There Any Correlation between Her2/neu Expression, Ki-67 Score, and Tumor Budding and Clinicopathological Parameters?—A Prospective Institution-Based Study

Saved in:

Bibliographic Details
Main Authors:	Susnata Khan, Senjuti Dasgupta, Asit Ranjan Deb
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2024-10-01
Series:	South Asian Journal of Cancer
Subjects:	colorectal carcinoma Her2/neu Ki-67 tumor budding tumor-infiltrating lymphocytes
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1789276
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunohistochemical Study of Ki-67 and HER2/neu and its Correlation with Clinicopathological Features in Surface Epithelial Tumors of the Ovary
by: Sameeksha Alva, et al.
Published: (2025-01-01)

Histopathological Study of Gastric Adenocarcinoma with Special Reference to Expression of HER2/neu and Ki-67 Assessed by Immunohistochemistry
by: Saiqa Nisar, et al.
Published: (2024-10-01)

Immunohistochemical expression of markers Ki-67, neun, synaptophysin, p53 and HER2 in medulloblastoma and its correlation with clinicopathological parameters Expressão imunoistoquímica dos marcadores Ki-67, neun, sinaptofisina, p53 e HER2 em meduloblastoma e sua correlação com os parâmetros clínico-patológicos
by: Rosalva Thereza Meurer, et al.
Published: (2008-06-01)

Expression of Human Epidermal Growth Factor Receptor (HER2/neu) and Proliferative Marker Ki-67 in Nonneoplastic, Preneoplastic, Neoplastic Lesions of Gallbladder and Its Association with Clinicopathological Parameters
by: Kiran Yadav, et al.
Published: (2025-01-01)

Tumour budding in invasive ductal breast carcinomas: correlation with clinicopathological prognostic parameters and hormone receptor status
by: Sachin Sebastian Francis, et al.
Published: (2025-02-01)

A study of histopathological spectrum and expression of Ki-67, TP53 in primary brain tumors of pediatric age group
by: Subhalakshmi Sengupta, et al.
Published: (2012-01-01)

Ki67 index importance in patients with breast cancer
by: O. Bondar
Published: (2024-12-01)

Application of multicolor flow cytometry in liquid biopsy of breast cancer
by: E. V. Kaigorodova, et al.
Published: (2023-10-01)

Neoplasias astrocitárias e correlação com as proteínas p53 mutada e Ki-67 Astrocytic neoplasms and correlation with mutate p53 and Ki-67 proteins
by: Gustavo Rassier Isolan, et al.
Published: (2005-12-01)

Immunohistochemical characteristics of breast cancer, increasing the risk of local reccurence after organosaving treatment
by: S. M. Demidov, et al.
Published: (2018-10-01)

Cyclooxygenase-2 and Ki67 Expression in Oral Leukoplakia: a Clinicopathological Study
by: Alper Sinanoglu, et al.
Published: (2015-06-01)

A correlation research of Ki67 index, CT features, and risk stratification in gastrointestinal stromal tumor
by: Huali Li, et al.
Published: (2018-09-01)

Assessment of the Relationship between Ki-67 Expression and Different Clinicopathological Factors of Adenoid Cystic Carcinoma: A Retrospective Immunohistochemical Study
by: Mohammed Al Zubidi, et al.
Published: (2025-03-01)

Clinical significance of changes in the expression level of markers of surrogate breast cancer subtypes in recurrent and metastatic foci (literature review)
by: Yu. S. Krumin, et al.
Published: (2021-03-01)

Stratification of G2 pancreatic neuroendocrine tumors using a Ten Percent Ki-67 index cut-off based on clinicopathological and molecular analyses
by: Yumiko Kageyama, et al.
Published: (2025-05-01)

An Immunohistochemical Study in Urothelial Carcinoma of HER2/neu in Iraqi Patients
by: Athraa Falah Alshimerry
Published: (2025-01-01)

Clinicopathological importance of immunohistochemical expression of OCT4, c-MYC and Ki-67 in colorectal cancer
by: Rabia Hursitoglu, et al.
Published: (2024-12-01)

Association between histologic grades and Ki67 score in breast cancer
by: Dr Shumaila Nawaz Khan Khan, et al.
Published: (2025-03-01)

Noninvasive prediction of Ki-67 expression level in IDH-wildtype glioblastoma using MRI histogram analysis: comparison and combination of MRI morphological features
by: Qiang Liang, et al.
Published: (2025-05-01)

The association between Ki-67 expression and survival in breast cancer subtypes: a cross-sectional study of Ki-67 cut-point in northern Thailand
by: Phanchaporn Wongmaneerung, et al.
Published: (2025-02-01)

Immunohistochemical Staining Properties of Osteopontin and Ki-67 in Feline Meningiomas
by: Gabriele Gradner, et al.
Published: (2024-11-01)

P63 and Ki-67 expression in radicular cyst
by: Mohammed Amjed Alsaegh, et al.
Published: (2023-09-01)

The importance of Ki-67 proliferation index in small cell lung cancer
by: Seda Beyhan Sağmen, et al.
Published: (2025-01-01)

NEW INDICATORS OF HSP27 FUNCTIONAL STATE IN BREAST CANCER CELLS WITH DIFFERENT VARIANTS OF HER2/NEU-STATUS
by: E. V. Kaigorodova, et al.
Published: (2016-02-01)

A deep learning model to predict Ki-67 positivity in oral squamous cell carcinoma
by: Francesco Martino, et al.
Published: (2024-12-01)

Study of Immunohistochemical Expression of p53 and Ki-67 in Oral Squamous Cell Carcinoma
by: Kajal Ranjan, et al.
Published: (2025-08-01)

Blood biomarkers and Ki-67 proliferation marker in breast cancer
by: A. A. Studenikina, et al.
Published: (2023-04-01)

A case of pathological complete regression in combined modality treatment of resectable Her2/neu-positive gastric cancer
by: A. V. Avgustinovich, et al.
Published: (2024-03-01)

Metastatic prolactinoma: case report with immunohistochemical assessment for p53 and Ki-67 antigens Prolactinoma metastático: relato de caso com avaliação imuno-histoquímica para os antígenos p53 e Ki-67
by: Paulo S. Crusius, et al.
Published: (2005-09-01)

Comparing non-machine learning vs. machine learning methods for Ki67 scoring in gastrointestinal neuroendocrine tumors
by: Nazanin Mola, et al.
Published: (2025-07-01)

Assessing functional suitability of a lyophilized formulation containing designed ankyrin repeat proteins for radionuclide imaging of HER2/neu overexpression in malignant tumors
by: R. N. Varvashenya, et al.
Published: (2024-10-01)

Prognostic significance of Ki-67 in assessing the risk of progression, relapse or metastasis in pheochromocytomas and paragangliomas
by: Zilan Luo, et al.
Published: (2025-12-01)

Expression of Ki-67 in Oral Lichen Planus: A Systematic Review and Meta-Analysis
by: Ayla Bahramian, et al.
Published: (2024-12-01)

MRI-based multiregional radiomics for preoperative prediction of Ki-67 expression in meningiomas: a two-center study
by: Ming Luo, et al.
Published: (2025-07-01)

Prognostic Importance of Ki-67 Expression in Early-Stage Glottic Larynx Cancer Treated with Radiotherapy
by: Gül Kanyılmaz, et al.
Published: (2023-10-01)

Role of topoisomerase II α and Ki -67 biomarkers in pituitary tumors
by: Chhanda Das, et al.
Published: (2023-12-01)

Interpretable model based on MRI radiomics to predict the expression of Ki-67 in breast cancer
by: Li Zhang, et al.
Published: (2025-04-01)

Prognostic value of immunohistochemical marker HER2/neu in patients resected for gastric cancer stage IIIA
by: O. M. Levyk
Published: (2014-04-01)

Prediction of Ki-67 expression in gastric gastrointestinal stromal tumors using histogram analysis of monochromatic and iodine images derived from spectral CT
by: Xianwang Liu, et al.
Published: (2024-12-01)

High Ki67 expression, HER2 overexpression, and low progesterone receptor levels in high-grade DCIS: significant associations with clinical practice implications
by: Hossein Schandiz, et al.
Published: (2025-01-01)